Ehlers-Danlos News
Ehlers-Danlos News is a digital platform intended to provide the Ehlers-Danlos syndrome (EDS) community with the most recent news and information on EDS, as well as first-hand community perspectives from our patient and caregiver columnists.
All articles on Ehlers-Danlos News are original content produced by in-house writers and editors. Occasionally, we seek the opinion of outside experts for interviews and Q&As.
The publishing team at Ehlers-Danlos News is made up of science writers and editors, most of whom have PhDs in the life sciences; veteran journalists; and columnists who are members of the EDS community. Together, they ensure that all content published on Ehlers-Danlos News is relevant, accurate, informative, relatable, and easy to understand.
Categories: Advertising, Biotech/Biomedical, Business, Health & Fitness, News, Science
Bionic ID: 638171
Advertising Options
Below are Ehlers-Danlos News advertising placement options to consider in your media planning and media buying.
-
E-Newsletter Advertising
- E-Newsletter
-
Other Advertising
- News
-
Social Advertising
- Facebook Post
- LinkedIn Post
- Twitter Post
-
Online Display Advertising
- 300x250 - Medium Rectangle - 300x250
- 728x90 - Leaderboard - 728x90
Learn More
To learn more about the Ehlers-Danlos News program, submit a request for information. Your request will be sent immediately to the Bionews, Inc. ad sales team.
Place an Order
To place an order, contact Ehlers-Danlos News or order electronically through Bionic Media Buying Software using ID 638171.